Analyst stock forecast
Beam Therapeutics Stock Forecast and Analyst Price Target
BEAM analyst target range, upside, consensus rating and coverage count.
Direct answer
Beam Therapeutics's average price target is $52.31.
The target implies +101.9% from the recorded current price, and the consensus rating is none.
The verified range is $26.00 to $80.00, with 13 analysts in the current consensus when available.
Forecast evidence checked August 4, 2026.
Verified data
- Current price
- $25.91
- Average price target
- $52.31
- High price target
- $80.00
- Low price target
- $26.00
- Target upside
- +101.9%
- Consensus rating
- none
- Analysts
- 13
- Evidence date
- August 4, 2026
- Valid through
- August 11, 2026